(b)(4): during processing of this complaint, attempts were made to obtain complete event, patient and device information.The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all relevant information.The clip delivery system referenced is filed under a separate medwatch report.
|
This is conservatively filed to report possible embolism, resulting in death.It was reported that the initial mitraclip procedure was performed on (b)(6) 2018, to treat functional mitral regurgitation (mr) with a grade of 3-4.A mitraclip was successfully implanted, reducing mr to 1.On (b)(6) 2018, it was noted the clip detached from the anterior leaflet and remained attached to the posterior leaflet (single leaflet device attachment (slda)) and the mr increased to 3-4.A second intervention was performed on (b)(6) 2019 in an attempt to treat the slda.After the transseptal puncture, the steerable guide catheter (sgc) was advanced to the left ventricle when the patient became unstable.Cardiopulmonary resuscitation was performed however the patient died due to hypoxia.The physician believed an embolism may have occurred but was not confirmed.No additional information was provided.
|
Internal file number - (b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.The reported patient effects of death, hypertension, respiratory failure, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The cause for potential embolism, hypertension, respiratory failure and death is unknown.Although a conclusive cause for the reported patient effect(s), and the relationship to the device, if any, cannot be determined, there is no indication of a product quality issue with respect to manufacture, design or labeling.
|